查看完整行情页>>
|
货币单位:美元(USD)
Avanir Pharmaceuticals (avnr)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 机构持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Baker Brother Life Sciences, L.P. |
32767078 |
12.00% |
491506170 |
0.20% |
1999-11-30
|
| T. Rowe Price Associates, Inc. |
28047222 |
12.00% |
420708330 |
0.10% |
1999-11-30
|
| Fidelity Management & Research (FMR) LLC |
20561721 |
12.00% |
308425815 |
0.10% |
1999-11-30
|
| BlackRock Institutional Trust Company |
12614904 |
12.00% |
189223560 |
0.10% |
1999-11-30
|
| 共同基金持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Fidelity® Select Biotechnology Portfolio |
10581952 |
5.50% |
-- |
-- |
2014-11-30
|
| iShares Russell 2000 Growth |
1420561 |
0.70% |
-- |
-- |
2015-01-08
|
| Lord Abbett Developing Growth Fund |
1443902 |
0.80% |
1443902 |
-- |
2014-09-30
|
| Fidelity Advisor® Biotechnology Fund |
1637599 |
0.80% |
-- |
-- |
2014-11-30
|
| Vanguard Extended Market Index Fund |
1735869 |
0.90% |
574 |
-- |
2014-11-30
|
| SPDR® S&P Pharmaceuticals ETF |
1807895 |
0.90% |
-- |
-- |
2015-01-08
|
| Oppenheimer Global Opportunities |
2000000 |
1.00% |
-- |
-- |
2014-11-30
|
| iShares Nasdaq Biotechnology |
2283746 |
1.20% |
5041 |
0.20% |
2015-01-08
|
| Vanguard Total Stock Mkt Idx |
2881958 |
1.50% |
46233 |
1.60% |
2014-11-30
|
| iShares Russell 2000 (AU) |
3142015 |
1.60% |
-26080 |
-0.80% |
2015-01-07
|
| Fidelity® Select Health Care Portfolio |
4600000 |
2.40% |
320000 |
7.50% |
2014-11-30
|
| T. Rowe Price Small Cap Stock Fund |
4604600 |
2.40% |
-7100 |
-0.20% |
2014-09-30
|
| T. Rowe Price New Horizons Fund |
6541700 |
3.40% |
923100 |
16.40% |
2014-09-30
|
| T. Rowe Price Health Sciences Fund |
9653370 |
5.00% |
848400 |
9.60% |
2014-09-30
|
| Fidelity Advisor® Health Care Fund |
1049700 |
0.50% |
101600 |
10.70% |
2014-11-30
|
